Xalatan · DIN 02231493 · 0.005% · Oph Sol-2.5mL Pk
Limited Use, Reason for Use code 171, 172, 387 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 171, 172, 387 required
Write on scriptone applicable Reason for Use code, 171 or 172 or 387 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 171, 172, 387
Reason for Use code 171
As first line treatment of elevated intraocular pressure in patients who cannot tolerate an ophthalmic beta-blocking agent or where beta-blocking agents are contraindicated.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 172
As second line monotherapy or combination therapy in patients who do not have an adequate intraocular pressure lowering response to ophthalmic beta-blocking agents.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 387
For use as adjunctive therapy with an ophthalmic beta-blocking agent in an urgent situation (e.g. patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective.
Coverage limit:
LU Authorization Period: Indefinite
Savings card: RxHelp ONE lists Xalatan (read 2026-09-10) — brand-name savings card, free; cannot be combined with another card on the same claim. (rxhelp.ca ↗)
1 brand, same coverage
Xalatan · DIN 02231493
Manufacturer: Upjohn Canada ULC; listing date 2000-01-17
Health Canada: Marketed since 2023-07-31 · brand XALATAN · ATC S01EE01 LATANOPROST · form Solution · route Ophthalmic · ingredients LATANOPROST 50 MCG/ML · company Bgp pharma ulc · schedule Prescription
Ministry pays: $9.5830 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02231493)
Source record
DIN 02231493: Xalatan
Raw flags: sec12=Y, sec3=Y
Item: 523600088; group id 629; item number 1598; lccId 00089; manufacturer id UJC
Source form: Oph Sol-2.5mL Pk; strength: 0.005%
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $36.2736; ministry $9.5830
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02231493
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50823
Interchangeable products
Apo-Latanoprost · DIN 02296527 · $9.5830
Co Latanoprost · DIN 02254786 · $9.5830
Gd-Latanoprost · DIN 02373041 · $9.5830
Jamp Latanoprost · DIN 02453355 · $9.5830
M-Latanoprost · DIN 02513285 · $9.5830
Med-Latanoprost · DIN 02426935 · $9.5830
Riva-Latanoprost · DIN 02341085 · $9.5830
Sandoz Latanoprost · DIN 02367335 · $9.5830
Shortage status: resolved shortage (ended March 23, 2023); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02231493
Shortage record checked October 6, 2026